Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas O Crawford

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Neuromuscular Disorders : NMD|September 1, 2004
Concerns about the design of clinical trials for spinal muscular atrophyThomas O Crawford
Annals of Neurology|November 26, 2002
The relationship of SMN to amyotrophic lateral sclerosisThomas O Crawford, Richard L Skolasky
The Journal of Clinical Investigation|August 2, 2021
Assuring long-term safety of highly effective gene-modulating therapeutics for rare diseasesThomas O Crawford, Charlotte J Sumner
The Journal of Pediatrics|August 24, 2014
Motor and cognitive delay in Duchenne muscular dystrophy: implication for early diagnosisKara T Mirski, Thomas O Crawford
Investigative Ophthalmology & Visual Science|February 28, 2002
Slow target-directed eye movements in ataxia-telangiectasiaRichard F Lewis, Thomas O Crawford
Nature Medicine|July 15, 2022
Early treatment is a lifeline for infants with SMACharlotte J Sumner, Thomas O Crawford
The Journal of Clinical Investigation|July 10, 2018
Two breakthrough gene-targeted treatments for spinal muscular atrophy: challenges remainCharlotte J Sumner, Thomas O Crawford
Pediatrics|July 19, 2006
The "slurp" test: bedside evaluation of bulbar muscle fatigueMichelle P Hudspeth, Kenton R Holden, Thomas O Crawford
Journal of Pediatric Orthopedics|February 14, 2022
Hip Pain in Patients With Spinal Muscular Atrophy: Prevalence, Intensity, Interference, and Factors Associated With Moderate to Severe PainAmy L Xu, Thomas O Crawford, Paul D Sponseller
Current Treatment Options in Neurology|February 13, 2009
Emerging treatment options for spinal muscular atrophyBarrington G Burnett, Thomas O Crawford, Charlotte J Sumner
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Neuromuscular Disorders : NMD|September 1, 2004
Concerns about the design of clinical trials for spinal muscular atrophyThomas O Crawford
Annals of Neurology|November 26, 2002
The relationship of SMN to amyotrophic lateral sclerosisThomas O Crawford, Richard L Skolasky
The Journal of Clinical Investigation|August 2, 2021
Assuring long-term safety of highly effective gene-modulating therapeutics for rare diseasesThomas O Crawford, Charlotte J Sumner
The Journal of Pediatrics|August 24, 2014
Motor and cognitive delay in Duchenne muscular dystrophy: implication for early diagnosisKara T Mirski, Thomas O Crawford
Investigative Ophthalmology & Visual Science|February 28, 2002
Slow target-directed eye movements in ataxia-telangiectasiaRichard F Lewis, Thomas O Crawford
Nature Medicine|July 15, 2022
Early treatment is a lifeline for infants with SMACharlotte J Sumner, Thomas O Crawford
The Journal of Clinical Investigation|July 10, 2018
Two breakthrough gene-targeted treatments for spinal muscular atrophy: challenges remainCharlotte J Sumner, Thomas O Crawford
Pediatrics|July 19, 2006
The "slurp" test: bedside evaluation of bulbar muscle fatigueMichelle P Hudspeth, Kenton R Holden, Thomas O Crawford
Journal of Pediatric Orthopedics|February 14, 2022
Hip Pain in Patients With Spinal Muscular Atrophy: Prevalence, Intensity, Interference, and Factors Associated With Moderate to Severe PainAmy L Xu, Thomas O Crawford, Paul D Sponseller
Current Treatment Options in Neurology|February 13, 2009
Emerging treatment options for spinal muscular atrophyBarrington G Burnett, Thomas O Crawford, Charlotte J Sumner
Pageof 12